New York State Common Retirement Fund Brainstorm Cell Therapeutics Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$3.14 - $4.09 $857 - $1,116	-273 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$3.01 - $4.01 $44,328 - $59,055	-14,727 Reduced 98.18%	273 $1,000
Q1 2021 May 11, 2021	BUY	$3.46 - $7.88 $32,178 - $73,284	9,300 Added 163.16%	15,000 $57,000
Q4 2020 Feb 08, 2021	SELL	$3.99 - $17.73 $75,012 - $333,324	-18,800 Reduced 76.73%	5,700 $26,000
Q2 2020 Aug 07, 2020	BUY	$4.42 - $12.66 $108,290 - $310,170	24,500 New	24,500 $275,000

10.9M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $39.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.